CABA Annual Cash & Cash Equivalents
$193.24 M
+$111.63 M+136.79%
31 December 2023
Summary:
As of January 23, 2025, CABA annual cash & cash equivalents is $193.24 million, with the most recent change of +$111.63 million (+136.79%) on December 31, 2023. During the last 3 years, it has risen by +$91.81 million (+90.52%). CABA annual cash & cash equivalents is now at all-time high.CABA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CABA Quarterly Cash And Cash Equivalents
$170.61 M
-$8.01 M-4.48%
30 September 2024
Summary:
As of January 23, 2025, CABA quarterly cash and cash equivalents is $170.61 million, with the most recent change of -$8.01 million (-4.48%) on September 30, 2024. Over the past year, it has dropped by -$4.68 million (-2.67%). CABA quarterly cash and cash equivalents is now -11.71% below its all-time high of $193.24 million, reached on December 31, 2023.CABA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CABA Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +136.8% | -2.7% |
3 y3 years | +90.5% | +44.3% |
5 y5 years | +485.3% | +140.2% |
CABA Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +136.8% | -11.7% | +261.7% |
5 y | 5-year | at high | +136.8% | -11.7% | +261.7% |
alltime | all time | at high | >+9999.0% | -11.7% | +416.7% |
Cabaletta Bio Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $170.61 M(-4.5%) |
June 2024 | - | $178.61 M(+1.9%) |
Mar 2024 | - | $175.29 M(-9.3%) |
Dec 2023 | $193.24 M(+136.8%) | $193.24 M(+67.3%) |
Sept 2023 | - | $115.50 M(-9.8%) |
June 2023 | - | $128.07 M(+36.5%) |
Mar 2023 | - | $93.84 M(+15.0%) |
Dec 2022 | $81.61 M(-33.2%) | $81.61 M(+33.4%) |
Sept 2022 | - | $61.16 M(+29.7%) |
June 2022 | - | $47.17 M(-20.8%) |
Mar 2022 | - | $59.55 M(-51.3%) |
Dec 2021 | $122.22 M | $122.22 M(+3.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $118.26 M(+18.9%) |
June 2021 | - | $99.50 M(+2.3%) |
Mar 2021 | - | $97.28 M(-4.1%) |
Dec 2020 | $101.43 M(-25.5%) | $101.43 M(-6.7%) |
Sept 2020 | - | $108.68 M(-3.0%) |
June 2020 | - | $112.10 M(-14.4%) |
Mar 2020 | - | $131.00 M(-3.8%) |
Dec 2019 | $136.20 M(+312.5%) | $136.20 M(+91.7%) |
Sept 2019 | - | $71.04 M(-5.6%) |
June 2019 | - | $75.26 M(+127.9%) |
Dec 2018 | $33.02 M(>+9900.0%) | $33.02 M |
Dec 2017 | $1000.00 | - |
FAQ
- What is Cabaletta Bio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Cabaletta Bio?
- What is Cabaletta Bio annual cash & cash equivalents year-on-year change?
- What is Cabaletta Bio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Cabaletta Bio?
- What is Cabaletta Bio quarterly cash and cash equivalents year-on-year change?
What is Cabaletta Bio annual cash & cash equivalents?
The current annual cash & cash equivalents of CABA is $193.24 M
What is the all time high annual cash & cash equivalents for Cabaletta Bio?
Cabaletta Bio all-time high annual cash & cash equivalents is $193.24 M
What is Cabaletta Bio annual cash & cash equivalents year-on-year change?
Over the past year, CABA annual cash & cash equivalents has changed by +$111.63 M (+136.79%)
What is Cabaletta Bio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CABA is $170.61 M
What is the all time high quarterly cash and cash equivalents for Cabaletta Bio?
Cabaletta Bio all-time high quarterly cash and cash equivalents is $193.24 M
What is Cabaletta Bio quarterly cash and cash equivalents year-on-year change?
Over the past year, CABA quarterly cash and cash equivalents has changed by -$4.68 M (-2.67%)